ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS
ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS
批准号:
6514545
负责人:
TERRY A VAN DYKE
金额:
$34.69万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2004-06-30
中文摘要
血管生成是肿瘤进展的重要组成部分,在此过程中,新的血管滋养生长中的肿瘤,促进肿瘤的快速扩张。最近,哈佛大学Folkman实验室从小鼠人肿瘤移植瘤中分离到两种血管生成抑制物(AngI),即血管抑素和内皮抑素。这些蛋白质抑制内皮细胞的增殖,当被引入小鼠皮下时,它们是有效的异种移植瘤生长的抑制因子。这种肿瘤似乎不会对这些因素产生抵抗力,这表明它们可以提供有效的长期癌症治疗。然而,需要更广泛的临床前实验来解决几个重要的问题。例如,异种移植模型代表了一个人工实验系统,因为细胞系用于小鼠的皮下肿瘤。对这类肿瘤的治疗可能不能反映发生在自然部位的新生肿瘤的反应。在肿瘤从头产生的转基因小鼠中进行评估是测试这种方法有效性的下一步。另一个问题是难以分离出足够的活性因子,即使是在小鼠的研究中也是如此,这使得人类的临床研究具有挑战性。编码这些因子的基因的体细胞输送将绕过生产大量纯化蛋白的需要。本研究旨在验证腺相关病毒(AAV)和腺病毒(Ad)载体体细胞基因转导新生转基因小鼠肿瘤模型的有效性。该方法还将扩展到至少一个额外的Angi,一种活性凝血酶原蛋白-1片段。其具体目的是:(1)鉴定和优化携带Angi基因的重组AAV和Ad载体(RAAV)的体内递送;(2)检测Angi基因对小鼠肌肉和肝脏分泌血清以及脑和乳腺组织的作用;(2)在特征良好的脉络丛脑瘤模型中测试Angi基因治疗(GT)的疗效;(3)使用与目标2相似的方法在非中枢神经系统转移性乳腺癌模型中测试Angi GT。
英文摘要
Angiogenesis is an essential component of tumor progression during which new blood vessels nourish growing tumors and facilitate rapid tumor expansion. Recently, two angiogenesis inhibitors (AngIs), angiostatin and endostatin, were isolated from human tumor xenografts in mice by the Folkman lab (Harvard). These proteins inhibit endothelial cell proliferation and are effective inhibitors of xenograft tumor growth when introduced into mice subcutaneously. Such tumors do not appear to develop resistance to these factors, suggesting that they could provide effective long-term therapy against cancer. However, more extensive preclinical experimentation is required to address several important issues. For example, the xenograft models represent an artificial experimental system, since cell lines are used to tumors subcutaneously in the mouse. Treatment of such tumors may not reflect the response of de novo tumors arising in natural sites. Assessment in genetically altered mice where tumors arise de novo is the next step in testing the efficacy of this approach. Another problem has been in the difficulty in isolating enough active factor for even the mouse studies, making human clinical studies challenging. Somatic delivery of the genes encoding these factors would circumvent the need to produce large quantities of purified protein. This proposal aims to test the efficacy of somatic gene delivery by adeno-associated virus (AAV) and adenovirus (ad) vectors into well-characterized de novo transgenic mouse tumor models. The approach will also be extended to at least one additional AngI, an active thrombospondin-1 fragment. The specific aims are to: (1) Characterize and optimize somatic delivery of recombinant AAV and ad vectors (rAAV) carrying the AngI genes to mouse muscle and liver for secretion to serum, and to brain and mammary tissue; (2) Test the therapeutic efficacy of genetic therapy (GT) with AngIs in a well characterized choroid plexus brain tumor model that undergoes a consistent transition to angiogenesis; (3) Test AngI GT in a non-CNS metastatic mammary tumor model using approaches similar to those in aim 2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:7957608
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2009
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:7722425
-
项目类别:
-
资助金额:$2.93万
-
财政年份:2008
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:7601071
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2007
-
负责人:TERRY A VAN DYKE
-
依托单位:
Animal Models Core
-
批准号:7068352
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2005
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:6977834
-
项目类别:
-
资助金额:$2.8万
-
财政年份:2004
-
负责人:TERRY A VAN DYKE
-
依托单位:
CORE--ANIMAL MODELS
-
批准号:7100667
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2004
-
负责人:TERRY A VAN DYKE
-
依托单位:
Core--Animal
-
批准号:6642936
-
项目类别:
-
资助金额:$26.58万
-
财政年份:2002
-
负责人:TERRY A VAN DYKE
-
依托单位:
ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS
-
批准号:6132955
-
项目类别:
-
资助金额:$34.97万
-
财政年份:2000
-
负责人:TERRY A VAN DYKE
-
依托单位:
ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS
-
批准号:6377900
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2000
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:6377688
-
项目类别:
-
资助金额:$90.61万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:6514298
-
项目类别:
-
资助金额:$110.86万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
CENTER TO CHARACTERIZE & MAINTAIN MUTANT MICE
-
批准号:6053577
-
项目类别:
-
资助金额:$85.75万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
Astrocytic Cancers: How, When, Where?
-
批准号:7127218
-
项目类别:
-
资助金额:$108.73万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:6658009
-
项目类别:
-
资助金额:$140.31万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:6175347
-
项目类别:
-
资助金额:$63.4万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
Astrocytic Cancers: How, When, Where?
-
批准号:7922413
-
项目类别:
-
资助金额:$7.53万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
Astrocytic Cancers: How, When, Where?
-
批准号:6733894
-
项目类别:
-
资助金额:$85.0万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS
-
批准号:6039349
-
项目类别:
-
资助金额:$34.53万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
A CAROLINA CENTER TO CHARACTERIZE & MAINTAIN MUTANT MICE
-
批准号:6188795
-
项目类别:
-
资助金额:$100.98万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位:
Astrocytic Cancers: How, When, Where?
-
批准号:6936431
-
项目类别:
-
资助金额:$108.06万
-
财政年份:1999
-
负责人:TERRY A VAN DYKE
-
依托单位: